Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL11690140 | 0.95 | — | — | |
| SCHEMBL28674846 | 0.95 | CA1 (0.64) | — | |
| SCHEMBL31387898 | 0.95 | CA1 (0.64) | — | |
| SCHEMBL11688874 | 0.85 | NFKB1 (0.59) | — | |
| SCHEMBL11690045 | 0.82 | CA1 (0.65) | — | |
| SCHEMBL20573580 | 0.81 | NFKB1 (0.55) | — | |
| SCHEMBL31618774 | 0.81 | NFKB1 (0.55) | — | |
| SCHEMBL125655 | 0.81 | — | — | |
| SCHEMBL1330920 | 0.81 | — | — | |
| SCHEMBL9704140 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013024028-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING PROTEINOPATHIES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2013-02-21 | — | — | WO | claimed |
| EP-3882252-B1 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC (US) | 2025-11-19 | — | — | EP | disclosed |
| EP-4092127-A1 | ENZYME-CATALYTIC METHOD FOR THE DIRECT STEREOSELECTIVE SYNTHESIS OF GAMMA-(ACYLOXY) CARBOXYLIC ACIDS | Tallinn University of Technology (EE) | 2022-11-23 | — | — | EP | disclosed |
| EP-3882252-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |
| US-11008346-B2 | Beta-lactamase inhibitors | VenatoRx Pharmaceuticals, Inc. (US) | 2021-05-18 | — | — | US | disclosed |
| EP-3154989-B1 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC (US) | 2021-03-24 | — | — | EP | disclosed |
| US-20200361962-A1 | BETA-LACTAMASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-11-19 | — | — | US | disclosed |
| US-9926336-B2 | Beta-lactamase inhibitors | VENATORX PHARMACEUTICALS (US) | 2018-03-27 | — | — | US | disclosed |
| US-20170342092-A1 | BETA-LACTAMASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-11-30 | — | — | US | disclosed |
| US-9783555-B2 | Beta-lactamase inhibitors | VenatoRx Pharmaceuticals, Inc. (US) | 2017-10-10 | — | — | US | disclosed |
| US-6323010-B1 | PROVIDING SUBSTRATES WHICH COMPRISE 2-HYDROXYBUTYRIC ACID IN BIOLOGICAL SYSTEM WHICH IS GENETICALLY ENGINEERED TO EXPRESS ONE OR MORE ENZYMES SELECTED FROM THE GROUP CONSISTING OF POLYHYDROXYALKANOATE SYNTHASE, ACYL-COA TRANSFERASE, ETC. | METABOLIX, INC. | 2001-11-27 | — | — | US | disclosed |
| EP-1078068-A2 | POLYHYDROXYALKANOATE BIOPOLYMER COMPOSITIONS | METABOLIX, INC. (US) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999061624-A2 | POLYHYDROXYALKANOATE BIOPOLYMER COMPOSITIONS | METABOLIX, INC. (US) | 1999-12-02 | — | — | WO | disclosed |
| EP-0958367-A1 | METHODS FOR THE BIOSYNTHESIS OF POLYESTERS | MONSANTO COMPANY (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1998039453-A1 | METHODS FOR THE BIOSYNTHESIS OF POLYESTERS | MONSANTO COMPANY (US) | 1998-09-11 | — | — | WO | disclosed |
| US-5488140-A | ANTICONVULSANTS | CIBA-GEIGY CORPORATION (US) | 1996-01-30 | — | — | US | disclosed |
| US-5294734-A | 1-phosphato-4-amino-pent-2-enoic acids and derivatives | CIBA-GEIGY CORP. (US) | 1994-03-15 | — | — | US | disclosed |
| US-4544503-A | REACTING HYDROXY BENZENESULFONATE WITH CARBON MONOXIDE AND OLEFIN | ETHYL CORPORATION (US) | 1985-10-01 | — | — | US | disclosed |
| US-4537724-A | Alkanoyloxybenzenesulfonate salt production | ETHYL CORPORATION (US) | 1985-08-27 | — | — | US | disclosed |
| EP-0125641-A2 | Alkanoyloxybenzenesulfonate salt production | ETHYL CORPORATION (US) | 1984-11-21 | — | — | EP | disclosed |